Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edward Kaye Insider Profile
11 Followers
Edward Kaye, SVP Interim CEO & CMO at Sarepta Therapeutics, holds 69.35K shares in Stoke Therapeutics (Ticker: STOK), holds 19.17K shares in Cytokinetics (Ticker: CYTK), holds 103.53K shares in Sarepta Therapeutics (Ticker: SRPT).
Edward Kaye Sarepta Therapeutics (SRPT)SVP Interim CEO & CMO
Sarepta Therapeutics (SRPT)
SVP Interim CEO & CMO
Ranked #13,032 out of 98,564 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+28.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Edward Kaye holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward Kaye
Edward Kaye's Trading History
Sarepta Therapeutics
Aug 07, 2017
SVP Interim CEO & CMO
Uninformative Buy
632.71K
$12.12M
Cytokinetics
Oct 03, 2023
Director
Uninformative Buy
12.49K
$1.26M
Stoke Therapeutics
Mar 19, 2024
CEO, Director
Uninformative Buy
67.90K
$780.19K
Avidity Biosciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Edward Kaye's performance on stock
You May Also Like
Edward Kaye insider profile FAQ
What is the percentage of profitable transactions made by Edward Kaye?
The percentage of profitable transactions made by Edward Kaye is 60%.
What is the average return per transaction made by Edward Kaye?
The average return per transaction made by Edward Kaye is 28.30%.
What stocks does Edward Kaye hold?
Edward Kaye holds: SRPT, CYTK, STOK, RNA stocks.
What was Edward Kaye’s latest transaction?
Edward Kaye latest transaction was an Uninformative Buy of $67.90K.
What was Edward Kaye's most profitable transaction?
Edward Kaye’s most profitable transaction was an Informative Buy of STOK stock on September 8, 2023. The return on the trade was 126.90%.
What is Edward Kaye's role in Sarepta Therapeutics?
Edward Kaye's role in Sarepta Therapeutics is SVP Interim CEO & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.